Stereotactic Prostate Cancer Ablative Re-Irradiation: A Systematic Review and Meta-Analysis (SPARE).
Prostate re-irradiation with SABR is associated with favourable short- and intermediate-term oncologic outcomes, including high local control and metastasis-free survival, with acceptable toxicity.